Search the Newsreel

National Vision Deadline Alert

Faruqi & Faruqi, LLP is investigating potential securities claims against National Vision Holdings, Inc. (NASDAQ: EYE) and reminds investors of the March 28, 2023 deadline to seek lead plaintiff status in a class action lawsuit. The lawsuit alleges that National Vision made false and …

Keyera Corp. (TSX:KEY) Retreats as Valuation Pressure and Pre-Earnings Caution Weigh on Sentiment

Sei Investments Co. Boosts Stock Holdings in National Vision Holdings, Inc. $EYE

Sei Investments Co. significantly increased its stake in National Vision Holdings, Inc. by 119.2% in the first quarter, now owning 213,722 shares valued at $5.5 million. This increase makes Sei Investments Co. a 0.27% shareholder in National Vision. The optical retailer recently reported stronger-than-expected …

EyePoint Pharmaceuticals Inc (EYPT) News, Articles, Events & Latest Updates

This article provides recent news and updates on EyePoint Pharmaceuticals Inc (EYPT), including its Q2 and Q1 earnings performance, analyst ratings, and insider stock transactions. It highlights EyePoint's financial results, such as beating revenue estimates in Q2 and Q1 2026, and mentions analyst consensus …

Earnings call transcript: Kits Eyecare rises on strong Q2 2026 growth

Weyerhaeuser (WY) Receives a Buy from Citi

Citi analyst Anthony Pettinari maintained a Buy rating for Weyerhaeuser (WY) with a price target of $29.00, citing his 5-star analyst status and strong track record. This positive outlook follows Weyerhaeuser's Q2 earnings, where the company reported a significant increase in net profit to …

Earnings Flash (EYPT) EyePoint, Inc. Reports Q2 Revenue $507,000, vs. FactSet Est of $390,000

EyePoint, Inc. (EYPT) reported second-quarter revenue of $507,000, surpassing the FactSet estimate of $390,000. The company is a clinical-stage biopharmaceutical firm focused on developing treatments for serious retinal diseases, with its lead product candidate, DURAVYU, currently in Phase III pivotal trials for wet age-related …

Earnings Flash (KITS.TO) KITS Eyecare Ltd. Reports Q2 Revenue C$58.4M, vs. FactSet Est of C$58.3M

EyePoint Q2 2026 earnings: Phase 3 spending widens the net loss

EyePoint (Nasdaq: EYPT) reported a widened diluted loss per share of $1.09 in Q2 2026, compared to $0.85 a year earlier, primarily due to increased spending on DURAVYU Phase 3 trials and manufacturing scale-up. Revenue significantly decreased to $0.5 million from $5.3 million, reflecting …

EYPT Looks 1591.3% Overvalued on GF Value™

EyePoint Pharmaceuticals (EYPT) is considered 1591.3% overvalued according to its GF Value™, primarily due to an extraordinary Price-to-Sales ratio of 111.19x, significantly higher than its historical median. The company, a clinical-stage biotech specializing in retinal disease treatments, is awaiting pivotal Phase 3 trial results …

AEye Apollo™ Lidar Validated on NVIDIA DRIVE AGX Thor™

Validation deepens AEye's collaboration with NVIDIA as the company continues to advance its next-generation transportation roadmap PLEASANTON, Calif., August 05, 2026--(BUSINESS WIRE)--AEye, Inc. (Nasdaq: LIDR), a global leader in software-defined, high-performance lidar solutions, today announced that its flagship Apollo™ lidar sensor has been validated …

Kits Eyecare Ltd. Provides Earnings Guidance for the Third Quarter of 2026

Pacer Advisors Inc. Decreases Stock Position in Mobileye Global Inc. $MBLY

HawkEye 360 Schedules Conference Call to Discuss Second Quarter 2026 Financial Results

HawkEye 360 announced it will report its second-quarter 2026 financial results after market close on Thursday, August 13, 2026. Management will host a conference call at 4:30 p.m. ET on the same day to discuss the results, with replay options available for 14 days. …

HawkEye 360 Schedules After-Hours Webcast for Q2 Results

HawkEye 360 (NYSE: HAWK) announced it will release its second quarter 2026 financial results on Thursday, August 13, 2026, after market close. Management will host a conference call and webcast at 4:30 p.m. ET to discuss the results, with a 14-day replay available. The …

HAWK|Hawkeye 360 Ord Shs (Proposed)|Price:24.620|Chg%:+2.260

Hawkeye 360 Ord Shs (Proposed) (HAWK) is trading at $25.19, up 1.94%, with a market capitalization of $2.34 billion. Analysts currently rate HAWK as a "Buy" with a target price of $35.625, representing a 44.17% upside. The company is a signals intelligence partner, designing …

EyePoint (EYPT) Reports Q2 Loss, Beats Revenue Estimates

Will CEO Exit, Buyback and Raised Outlook Change Mobileye Global's (MBLY) Narrative

[10-Q] EyePoint, Inc. Quarterly Earnings Report

Kits Eyecare (KITS) Earnings Date and Reports 2026 $KITS

AudioEye, Inc. (AEYE) stock price, news, quote and history

This article provides a detailed overview of AudioEye, Inc. (AEYE) stock, including its current price, historical performance, key financial statistics, and company profile. It highlights the company's software and services for digital accessibility, aiming to convert content into accessible formats for people regardless of …

Eyepoint Pharma earnings on deck ahead of pivotal trial data By Investing.com

Eyepoint Pharmaceuticals Inc. is set to release its second-quarter earnings, with investor attention primarily focused on any updates regarding its pivotal Phase 3 LUGANO trial data for Duravyu, expected in August 2026. While analysts anticipate a loss of 95 cents per share on revenue …

Goforth to retire after 50 years at Weyerhaeuser

Jerry Goforth is retiring from Weyerhaeuser after 50 years, having started at the Philadelphia mill at age 21. Throughout his career, he worked in various roles, became a saw filing manager, and significantly contributed to the evolution of safety practices at the mill. Goforth …

Weyerhaeuser Q2 profit climbs with improved timberland sales

Weyerhaeuser reported a significant increase in Q2 net earnings to $162 million, up from $87 million in the same period last year, driven by improved timberland sales and divestitures. The company's adjusted EBITDA was $310 million, and it anticipates slightly higher earnings in Q3 …

National Vision Shareholder Notice

Faruqi & Faruqi, LLP is investigating potential claims against National Vision Holdings, Inc. (NASDAQ: EYE) and reminds investors of the March 28, 2023 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit. The lawsuit alleges that National Vision …

Understanding the Setup: (AEYE) and Scalable Risk

This article analyzes Audioeye Inc. (NASDAQ: AEYE), highlighting weak sentiment across all time horizons supporting a short bias. It identifies a mid-channel oscillation pattern and an exceptional 201.0:1 risk-reward setup targeting a 39.5% gain versus 0.2% risk. The piece outlines three distinct AI-generated trading …

EyePoint Pharmaceuticals Inc (EYPT) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for EyePoint Pharmaceuticals Inc (EYPT), highlighting its current risk score of 4.82, which ranks it 80th out of 155 in the Pharmaceuticals industry. The company's beta of 1.74 indicates higher volatility compared to the S&P 500. The report …

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Trading Down 5.3% - Here's Why

Nova Eye Medical Reports Lapse of 100,000 Unexercised Options

Lotus Eye Hospital & Institute Ltd is Rated Sell

National Vision Holdings, Inc. Revenue Breakdown – FWB:7NV

National Vision Holdings, Inc. (FWB:7NV) generated 1.69 billion EUR in revenue last year, primarily from its "Owned & Host" segment. The United States was the largest contributor to its revenue. This article provides a breakdown of the company's financial performance by segments and geographic …

Weyerhaeuser Company (WY) Stock Price | Live Quotes & Charts | NYSE

This page provides live stock quotes and charts for Weyerhaeuser Company (WY) on the NYSE, showing its current price and daily change. It also includes sections for analyst ratings and earnings information, although specific data for WY's ratings and earnings is currently unavailable. The …

Mobileye Global Inc. (NASDAQ: MBLY) director adds 12,360 shares in trust purchase

Mobileye Global Inc. director Frank D. Yeary purchased 12,360 shares of Class A common stock at $7.98 per share on July 30, 2026. The shares were acquired indirectly through the Sea Turtle Revocable Trust, of which Yeary is the trustee. Following this transaction, Yeary …

AudioEye (AEYE) Rises Higher Than Market: Key Facts

AudioEye (AEYE) ended the recent trading session at $5.91, demonstrating a +2.07% change from the preceding day's closing price. The stock exceeded the S&P 500, which registered a gain of 1.48% for the day. Elsewhere, the Dow gained 1.32%, while the tech-heavy Nasdaq added …

TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?

Key Points Interested in National Vision Holdings, Inc.? Here are five stocks we like better. Taiwan Semiconductor executives and directors, including the CEO, CFO, and COO, have made roughly $800,000 in open-market insider stock purchases since early July. Despite a post-earnings share price decline …

Truist raises Weyerhaeuser stock price target on earnings beat By Investing.com

Truist Securities has increased its price target for Weyerhaeuser (NYSE:WY) shares from $27 to $28, maintaining a Hold rating, following the company's Q2 operating earnings per share of $0.13, which surpassed analyst estimates. Despite the stock appearing overvalued relative to its Fair Value according …